Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 11/20 | 0.54 |
| ▸ | HTR2B | P41595 | 6/20 | 0.54 |
| ▸ | HTR2A | P28223 | 5/20 | 0.54 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6752904 | 0.94 | HTR2C (0.51) | HTR2CHTR2BHTR2AKDM4CSLC6A2 | |
| SCHEMBL5638490 | 0.88 | HTR2C (0.56) | HTR2CHTR2BHTR2A | |
| SCHEMBL5637064 | 0.88 | HTR2C (0.56) | HTR2CHTR2BHTR2A | |
| SCHEMBL5636468 | 0.86 | HTR2C (0.75) | HTR2CHTR2BHTR2A | |
| SCHEMBL5637201 | 0.86 | HTR2C (0.56) | HTR2CHTR2BHTR2A | |
| SCHEMBL5636401 | 0.86 | HTR2C (0.45) | HTR2CHTR2BHTR2AKDM4CKCNH2 | |
| SCHEMBL5635487 | 0.86 | HTR2C (0.45) | HTR2CHTR2BHTR2AKDM4C | |
| SCHEMBL5637404 | 0.84 | HTR2C (0.48) | HTR2CHTR2BHTR2AKCNH2 | |
| SCHEMBL5636676 | 0.84 | HTR2C (0.44) | HTR2CHTR2BHTR2A | |
| SCHEMBL5635916 | 0.84 | HTR2C (0.44) | HTR2CHTR2BHTR2ASLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39679-E1 | Substituted heterocycle fused gamma-carbolines | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-06-05 | — | — | US | disclosed |
| US-6713471-B1 | SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | disclosed |